Dr. Bansal has been on faculty at Mount Sinai since 2001. In addition to maintaining an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV, Dr. Bansal held many different leadership roles at Mount Sinai, including Transplant Hepatology Fellowship Director, Director of Translational Research, Medical Director of Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these latter roles, she helped generate increased quality dollars in value-based contracts, created Mount Sinai's first ambulatory pharmacy program and addressed broad population health needs. She has also served as the principal investigator for numerous clinical trials for MASH/NASH. At the international/national levels, she held the position of Secretary for the American Association for the Study of Liver and currently serves as the Director of the newly formed MASLD/MASH (NAFLD/NASH) Center of Excellence at Mount Sinai. In January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System.